RDHL

Redhill Biopharma

15 hedge funds and large institutions have $20.6M invested in Redhill Biopharma in 2015 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 0 reducing their positions, and closing their positions.

Holders
15
Holders Change
+5
Holders Change %
+50%
% of All Funds
0.4%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
5
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
O
1
OrbiMed
New York
$9.98M 685,800 +80,000 +13%
BC
2
Broadfin Capital
New York
$7.05M 484,281 +232,772 +93%
SM
3
Sabby Management
Florida
$1.57M 107,956 +107,956 New
CS
4
Candriam SCA
Luxembourg
$1.04M 71,267
Goldman Sachs
5
Goldman Sachs
New York
$422K 29,000
BHB
6
Bank Hapoalim BM
Israel
$337K 23,131 +23,131 New
MMG
7
Monetary Management Group
Missouri
$57K 3,890
Wells Fargo
8
Wells Fargo
California
$44K 3,000
TRCT
9
Tower Research Capital (TRC)
New York
$38K 2,637 +1,489 +130%
Bank of America
10
Bank of America
North Carolina
$15K 1,000
Deutsche Bank
11
Deutsche Bank
Germany
$14K 1,000 +1,000 New
UBS Group
12
UBS Group
Switzerland
$11K 778 +427 +122%
Morgan Stanley
13
Morgan Stanley
New York
$4K 280 +96 +52%
TWA
14
TCI Wealth Advisors
Arizona
$4K 300 +300 New
Citigroup
15
Citigroup
New York
$0 25 +25 New